Search

Your search keyword '"efficiency of therapy"' showing total 2 results
Start Over Descriptor "efficiency of therapy" Language english
2 results on '"efficiency of therapy"'

1. Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region

Author

Elena Efimovna Petryaykina, Olga Viktorovna Dukhareva, Irina Georgievna Rybkina, Ekaterina Alexandrovna Pronina, Tatiana Dmitrievna Mikhaylova, Irina Viktorovna Garyaeva, Eleonora Tavanovna Mandzhieva, Igor Eduardovich Volkov, and Natalya Mikhailovna Grenkova

Subjects
type 1 diabetes mellitus, children and adolescents, insulin pump therapy, glycated hemoglobin, insulin requirement, efficiency of therapy, Nutritional diseases. Deficiency diseases, RC620-627
Abstract

Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (p

Published
2009
Full Text
View/download PDF

2. Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region

Author

Natalya Mikhailovna Grenkova, Irina Georgievna Rybkina, Ekaterina Alexandrovna Pronina, Olga Viktorovna Dukhareva, Eleonora Tavanovna Mandzhieva, E E Petryaykina, Tatiana Dmitrievna Mikhaylova, Igor Eduardovich Volkov, and Irina V. Garyaeva

Subjects
Insulin pump, Pediatrics, medicine.medical_specialty, RC620-627, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin analog, insulin pump therapy, Insulin dose, chemistry.chemical_compound, efficiency of therapy, Endocrinology, Internal medicine, Internal Medicine, medicine, In patient, Nutritional diseases. Deficiency diseases, Type 1 diabetes, business.industry, Insulin, medicine.disease, chemistry, children and adolescents, Metabolic control analysis, insulin requirement, Glycated hemoglobin, business, type 1 diabetes mellitus, glycated hemoglobin
Abstract

Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA 1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA 1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (p Conclusion. Insulin pump therapy is an efficacious tool for the improvement of metabolic control in children and adolescents with poorly compensated CD1 regardless of age and duration of the disease.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results